Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

    Investing

    • Inheritance TaxInheritance Tax
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Client Area and Conectus Portal
  • Contact Us

Market News - Page 252

6 September 2022

Wynnstay Group plc September 2022 Trading Update

The Board of Wynnstay, the agricultural supplies group, is pleased to provide the following update on trading for the current financial year ending 31 October 2022….

6 September 2022

Renold plc September 2022 AGM Trading Update

Renold, a leading international supplier of industrial chains and related power transmission products, is pleased to provide a trading update covering the five months ended 31 August 2022 (the “Period”) ahead of the Company's Annual General Meeting (“AGM”) being held at 11 am today….

6 September 2022

DS Smith plc – Trading Statement September 2022

DS Smith today issues a trading update in respect of the period since …

6 September 2022

Berkeley group Holdings September 2022 Trading Update

The Berkeley Group Holdings plc (“Berkeley” or the “Company”) is holding its Annual General Meeting ('AGM') today, at which it will provide the following Trading Update covering the period from 1 May 2022 to 31 August 2022….

5 September 2022

AstraZeneca plc Forxiga Approved in China for CKD

Forxiga approved in China for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes…

5 September 2022

AstraZeneca plc Imfinzi Approved in US for Biliary Tract Cancer

Imfinzi plus chemotherapy approved in the US as the first immunotherapy regimen for patients with advanced biliary tract cancer…

5 September 2022

Vistry Group plc Recommended Cash and Share Combination of Vistry Group and Countryside Partnerships

To be effected by means of a scheme of arrangement under Part 26 of the Companies Act 2006
…

1 September 2022

Reckitt Benkiser Group Directorate Change- Laxman Narashimhan Steps Down as CEO

Laxman will be replaced by Nicandro Durante, current Senior Independent Director, who will step into the role of CEO, as the Board evaluates and selects the future leadership….

Posts navigation

  • «
  • 1
  • …
  • 250
  • 251
  • 252
  • 253
  • 254
  • …
  • 858
  • »

Home > Market News > Page 252

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Client Area and Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© Copyright 2010-2025. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG